4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001576280-25-000213
Co-Chief Executive Officer sold 100,000 shares at an average $50.88 ($5,087,630)
- Co-Chief Executive Officer gave up 14,603 shares (to pay taxes)
- Co-Chief Executive Officer acquired 28,812 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Talasaz AmirAli · Co-Chief Executive Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,815 | 2,074,271 | D | ||
| 2025-06-30 | Shares withheld for taxes : show line 2 in the form 10b5-1 | −2,441 | $52.04 | $127,030 | 2,071,830 | D |
| 2025-07-01 | Sale : show line 3 in the form 10b5-1 | −72,068 | $50.67 | $3,651,794 | 1,999,762 | D |
| 2025-07-01 | Sale : show line 4 in the form 10b5-1 | −27,932 | $51.40 | $1,435,836 | 1,971,830 | D |
| 2025-07-01 | Exercise or conversion : show line 5 in the form 10b5-1 | +23,997 | 1,995,827 | D | ||
| 2025-07-01 | Shares withheld for taxes : show line 6 in the form 10b5-1 | −12,162 | $50.71 | $616,735 | 1,983,665 | D |
| Open-market sales · 100,000 sh · avg $50.88 · $5,087,630 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-30 | Exercise or conversion : show line 7 in the form 10b5-1 Restricted Stock Units | −4,815 | $0.00 | 4,815 | 9,629 | D |
| 2025-07-01 | Exercise or conversion : show line 8 in the form 10b5-1 Restricted Stock Units | −23,997 | $0.00 | 23,997 | 143,983 | D |
Loading xslF345X05/wk-form4_1751505523.xml…